Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policyAdeera Levin, Robert G. Nelson, Chih-Wei Yang et al.|The Lancet|2017Cited by 923
Cyclin kinase inhibitors are increased during experimental membranous nephropathy: Potential role in limiting glomerular epithelial cell proliferation in vivoStuart J. Shankland, William G. Couser, Jürgen Floege et al.|Kidney International|1997Cited by 129
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trialPK Judge, A. Q. Adeleke, Natalie Staplin et al.|The Lancet Diabetes & Endocrinology|2023Cited by 107
Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis.Jeffrey Laurence, Santiago Rodrı́guez de Córdoba, Hermann Haller et al.|PubMed|2016Cited by 89
Comprehensive assay for the molecular profiling of cancer by target enrichment from formalin‐fixed paraffin‐embedded specimensShinji Kohsaka, Hiroyuki Mano, Kenji Tatsuno et al.|Cancer Science|2019Cited by 69